George Parker - IShares Medical Independent Chairman of the Board of Trustees
| IHI Etf | USD 60.35 0.05 0.08% |
Dr. George G.C. Parker, Ph.D., serves as an Independent Chairman of the Board of Trustees of Ishares Dow Jones US Medical Devices Index Fund. He was a Trustee of the Trust since 2000 and Chairman of the Trusts Board since 2010. Mr. Parker served as Lead Independent Trustee of the Trust from 2006 until 2010 and Chairman of the Nominating and Governance Committee for the Trust from 2002 until 2010. Mr. Parker has served as a Director of iShares, Inc. since 2002, Chairman of iShares, Inc.s Board since 2010, Lead Independent Director of iShares, Inc. from 2006 until 2010, Chairman of the Nominating and Governance Committee for iShares, Inc. from 2002 until 2010, a Director of iShares MSCI Russia Capped Index Fund, Inc. since 2010 and Chairman of iShares MSCI Russia Capped Index Fund, Inc.s Board since 2010. Mr. Parker also serves as Director on four other boards. Mr. Parker is the Dean Witter Distinguished Professor of Finance at the Stanford Graduate School of Business. He teaches courses in Corporationrationrate Finance in the MBA Program, Stanford Sloan Program for Executives, and in various other Executive Education Programs at Stanford University. Mr. Parkers teaching and research interests are primarily in the field of corporate finance, management of financial institutions, and corporate governance, and he has written numerous case studies related to these subjects. He has also authored several articles on capital structure, risk management, and corporate valuation
| Age | 80 |
| Tenure | 14 years |
| Professional Marks | MBA |
| Issuer | iShares |
| Inception Date | 2006-05-01 |
| Benchmark | Dow Jones U.S. Select Medical Equipment Index |
| Entity Type | Regulated Investment Company |
| Asset Under Management | 4.92 Billion |
| Average Trading Valume | 478,081.5 |
| Asset Type | Equity |
| Category | Sector |
| Focus | Health Care |
| Market Concentration | Developed Markets |
Similar Fund Executives
| Found 1 records | One Year Return | ||
| Lee Kranefuss | iShares Aerospace Defense | 53 | |
iShares Medical Devices Money Managers
| Geoffrey Flynn, Chief Operating Officer, Executive Vice President | ||
| Robert Silver, Independent Trustee | ||
| John Kerrigan, Independent Trustee | ||
| Madhav Rajan, Independent Trustee | ||
| Matt Tucker, Vice President | ||
| Cecilia Herbert, Independent Trustee | ||
| Michael Latham, President Trustee | ||
| Jack Gee, Chief Financial Officer, Treasurer | ||
| Charles Hurty, Independent Trustee | ||
| Eilleen Clavere, Secretary | ||
| George Parker, Independent Chairman of the Board of Trustees | ||
| John Martinez, Independent Trustee | ||
| Amy Schioldager, Executive Vice President | ||
| Robert Kapito, Trustee | ||
| Ira Shapiro, Vice President Chief Legal Officer |
IShares Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is IShares Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Price To Earning | 24.14 X | |||
| Price To Book | 3.03 X | |||
| Price To Sales | 3.38 X | |||
| Number Of Employees | 15 | |||
| Beta | 1.04 | |||
| Total Asset | 5.79 B | |||
| One Year Return | 22.20 % | |||
| Three Year Return | (2.00) % | |||
| Five Year Return | 7.50 % | |||
| Ten Year Return | 13.10 % |
Currently Active Assets on Macroaxis
When determining whether iShares Medical Devices offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IShares Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ishares Medical Devices Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Ishares Medical Devices Etf:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in iShares Medical Devices. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
The market value of iShares Medical Devices is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Medical's value that differs from its market value or its book value, called intrinsic value, which is IShares Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Medical's market value can be influenced by many factors that don't directly affect IShares Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.